Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Satoshi Yamasaki
Observed name:
S. Yamasaki
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Saitama International Medical Center,
Saitama Medical University
ORCID:
0000-0003-4722-9315
Observed ORCID:
0000-0003-4722-9315
OpenAlex ID:
A5033009809
Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2022
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
·
Cancer Research
·
47
PDF
A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
·
Cancer Research Communications
·
9
PDF
The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment
2026
·
Shota Takei
, Satoshi Yamasaki
, et al.
·
Nature Communications
·
6
PDF
Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations
2025
·
Atsuto Mouri
, Kyoichi Kaira
, et al.
·
Cancer Immunology Immunotherapy
·
2
PDF
1067P Discovery of a new CD4+ T cell cluster that correlates PD-1 blockade efficacy
2022
·
H. Kagamu
, S. Yamasaki
, et al.
·
Annals of Oncology
·
1
Abstract 4251: Th7R cells: CD4+ T-cell partners that drive Tpex-mediated antitumor immunity in the tumor microenvironment
2026
·
Shota Takei
, Ou Yamaguchi
, et al.
·
Cancer Research
Abstract 326: Association of off targets of ALK inhibitors with their adverse reactions revealed by a novel comprehensive phosphorylation profiling platform.
2026
·
Katsuhisa Horimoto
, Satoshi Mikami
, et al.
·
Cancer Research
Correction: Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study
2026
·
Takatsugu Fujii
, Masataka Hirasaki
, et al.
·
BMC Gastroenterology
PDF
Figure S1,S2,S3,S4,S5,S6,S7,S8,S9 and S10 from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2025
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
PDF
Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2025
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
Supplementary materials from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2025
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
Table S1, S3 and S8 from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
2025
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
Abstract 3962: A CCR6+Th1-like CD4+T-cell cluster involved in HEV formation predicted lung cancer patients requiring anti-CTLA-4 therapy
2024
·
Hiroshi Kagamu
, Satoshi Yamasaki
, et al.
·
Cancer Research
Table S1, Table S2 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Table S1, Table S2 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Supplementary Figure S1 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
PDF
TABLE 1 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
FIGURE 6 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
FIGURE 1 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Supplementary Figure S3 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
FIGURE 2 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Supplementary Figure S2 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
FIGURE 5 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Supplementary Figure S4 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
PDF
Supplementary Figure S1 from A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
2023
·
Akitoshi Yanagihara
, Satoshi Yamasaki
, et al.
Show more works
View as search
Works count:
43
Citation count:
65
H-index:
3
I10-index:
1
Year
Topic
Type